These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38272301)

  • 21. Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain.
    Samarasinghe SR; Samaranayake N; Kariyawasam UL; Siriwardana YD; Imamura H; Karunaweera ND
    BMC Genomics; 2018 Nov; 19(1):843. PubMed ID: 30486770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options for visceral leishmaniasis.
    Monge-Maillo B; López-Vélez R
    Drugs; 2013 Nov; 73(17):1863-88. PubMed ID: 24170666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Tracking of the
    Moulik S; Sengupta S; Chatterjee M
    Front Cell Infect Microbiol; 2021; 11():623437. PubMed ID: 33692966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.
    Sharma P; Gurumurthy S; Duncan R; Nakhasi HL; Salotra P
    Parasitol Int; 2010 Jun; 59(2):262-4. PubMed ID: 19963076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOLiD™ sequencing of genomes of clinical isolates of Leishmania donovani from India confirm leptomonas co-infection and raise some key questions.
    Singh N; Chikara S; Sundar S
    PLoS One; 2013; 8(2):e55738. PubMed ID: 23418454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Leishmania donovani and L. tropica in Ethiopian wild rodents.
    Kassahun A; Sadlova J; Dvorak V; Kostalova T; Rohousova I; Frynta D; Aghova T; Yasur-Landau D; Lemma W; Hailu A; Baneth G; Warburg A; Volf P; Votypka J
    Acta Trop; 2015 May; 145():39-44. PubMed ID: 25700710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
    Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
    J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
    Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced case of PKDL due to delayed treatment: A rare case report.
    Topno RK; Rabi Das VN; Kumar M; Madhukar M; Pandey K; Verma N; Agrawal K; Lal CS; Siddiqui NA; Bimal S; Das P
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008052. PubMed ID: 32203500
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Ramalingam K; Gangwar S; Balodi DC; Anand A; Yadav S; Biswas S; Karunakaran Sasikala AK; Gupta KC; Batra S; Goyal N
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0236121. PubMed ID: 35852367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings.
    Santana W; de Oliveira SSC; Ramos MH; Santos ALS; Dolabella SS; Souto EB; Severino P; Jain S
    Chem Biodivers; 2021 Sep; 18(9):e2100336. PubMed ID: 34369662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmaniasis.
    Herwaldt BL
    Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India.
    Dey A; Singh S
    Infect Genet Evol; 2007 Mar; 7(2):219-22. PubMed ID: 17027344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Sanz MG; Lima MA; Mitra G; Verma N; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2611. PubMed ID: 24392171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.
    Reimão JQ; Pita Pedro DP; Coelho AC
    Expert Opin Drug Discov; 2020 Jun; 15(6):647-658. PubMed ID: 32202449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmaniasis chemotherapy--challenges and opportunities.
    Croft SL; Olliaro P
    Clin Microbiol Infect; 2011 Oct; 17(10):1478-83. PubMed ID: 21933306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?
    El Hassan AM; Khalil EA
    Trop Med Int Health; 2001 Sep; 6(9):743-4. PubMed ID: 11555443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.